D.E. Shaw & Co’s Array Biopharma Inc ARRY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-542,638
| Closed | -$25.1M | – | 2887 |
|
|
2019
Q2 | $25.1M | Buy |
542,638
+461,244
| +567% | +$21.4M | 0.03% | 503 |
|
|
2019
Q1 | $1.98M | Buy |
81,394
+64,794
| +390% | +$1.58M | ﹤0.01% | 1571 |
|
|
2018
Q4 | $237K | Sell |
16,600
-20,043
| -55% | -$286K | ﹤0.01% | 2324 |
|
|
2018
Q3 | $557K | Buy |
+36,643
| New | +$557K | ﹤0.01% | 2037 |
|
|
2018
Q2 | – | Sell |
-14,218
| Closed | -$232K | – | 2781 |
|
|
2018
Q1 | $232K | Sell |
14,218
-222,218
| -94% | -$3.63M | ﹤0.01% | 2324 |
|
|
2017
Q4 | $3.03M | Buy |
236,436
+71,503
| +43% | +$915K | ﹤0.01% | 1309 |
|
|
2017
Q3 | $2.03M | Buy |
+164,933
| New | +$2.03M | ﹤0.01% | 1456 |
|
|
2017
Q2 | – | Sell |
-15,209
| Closed | -$136K | – | 2658 |
|
|
2017
Q1 | $136K | Buy |
+15,209
| New | +$136K | ﹤0.01% | 2322 |
|
|
2016
Q4 | – | Sell |
-20,681
| Closed | -$140K | – | 2731 |
|
|
2016
Q3 | $140K | Buy |
+20,681
| New | +$140K | ﹤0.01% | 2377 |
|
|
2016
Q2 | – | Sell |
-15,428
| Closed | -$46K | – | 2767 |
|
|
2016
Q1 | $46K | Sell |
15,428
-13,334
| -46% | -$39.8K | ﹤0.01% | 2532 |
|
|
2015
Q4 | $121K | Buy |
28,762
+1,603
| +6% | +$6.74K | ﹤0.01% | 2515 |
|
|
2015
Q3 | $124K | Buy |
+27,159
| New | +$124K | ﹤0.01% | 2429 |
|
|
2015
Q2 | – | Sell |
-41,750
| Closed | -$308K | – | 2792 |
|
|
2015
Q1 | $308K | Sell |
41,750
-313,319
| -88% | -$2.31M | ﹤0.01% | 2241 |
|
|
2014
Q4 | $1.68M | Buy |
+355,069
| New | +$1.68M | ﹤0.01% | 1439 |
|
|
2014
Q1 | – | Sell |
-37,935
| Closed | -$190K | – | 2675 |
|
|
2013
Q4 | $190K | Sell |
37,935
-30,531
| -45% | -$153K | ﹤0.01% | 2317 |
|
|
2013
Q3 | $426K | Sell |
68,466
-466,617
| -87% | -$2.9M | ﹤0.01% | 1952 |
|
|
2013
Q2 | $2.43M | Buy |
+535,083
| New | +$2.43M | ﹤0.01% | 1099 |
|